Funded Tech Companies

DNAtriX

DNAtriX is a biopharmaceutical tech company, based in Houston. Financial backing was provided by private investors, Morningside Group and Targeted Technology Fund.

Company Overview

Contact Information

Company Background Information

Overview

DNAtrix is a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer. DNAtrix s lead product, DNX-2401, is a modified common cold virus that targets and kills cancer cells selectively.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/26/2018

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Frank Tufaro

        

Chief Financial Officer

Brian Mooney

        

VP - Bus. Development

Brett Ewald

        

VP - Manufacturing

Erin Mitchell

        

VP - R & D

Karen Gammon

        

VP - R & D

Imre Kovesdi

        

VP - R & D

Joan Robbins

        

Company Investors

• Morningside Group (Reenie McCarthy)
• Targeted Technology Fund
• Mercury Fund (Daniel Watkins)
• Mercury Fund (Dan Watkins)
• Threshold Ventures

Browse more funded tech companies:

DNAsimple | DNSFilter

Share this article

About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary